Insider Transactions in Q1 2025 at Candel Therapeutics, Inc. (CADL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2025
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,428
-11.62%
|
$72,996
$7.22 P/Share
|
|
Jan 15
2025
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,704
-7.93%
|
$151,928
$7.22 P/Share
|
|
Jan 15
2025
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
9,511
-18.1%
|
$66,577
$7.22 P/Share
|
|
Jan 15
2025
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,322
-12.89%
|
$100,254
$7.22 P/Share
|
|
Jan 15
2025
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,534
-10.9%
|
$94,738
$7.22 P/Share
|
|
Jan 08
2025
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,799
-10.74%
|
$86,392
$8.22 P/Share
|
|
Jan 08
2025
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,545
-11.58%
|
$116,360
$8.22 P/Share
|
|
Jan 08
2025
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,172
-7.18%
|
$169,376
$8.22 P/Share
|
|
Jan 08
2025
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
9,971
-15.95%
|
$79,768
$8.22 P/Share
|
|
Jan 08
2025
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,673
-9.92%
|
$109,384
$8.22 P/Share
|